Aaron Goldman, USA



Aaron Goldman, PhD is heading research and development and immuno-oncology at Mitra Biotech, a personalized cancer medicine company headquartered in Boston MA, USA. He is also a faculty member at Harvard Medical School and Principal Investigator as well as Associate Bioengineer at Brigham and Women's Hospital where he is investigating the biological mechanisms of drug resistance in cancer. He is an Early Career Award Recipient from the Breast Cancer Alliance, an American Cancer Society fellow and ACS legislative ambassador.